Legal & General Group’s Acorda Therapeutics, Inc. ACOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-1,060
| Closed | -$119K | – | 3493 |
|
|
2020
Q1 | $119K | Buy |
1,060
+51
| +5% | +$5.73K | ﹤0.01% | 2365 |
|
|
2019
Q4 | $265K | Buy |
1,009
+44
| +5% | +$11.6K | ﹤0.01% | 2336 |
|
|
2019
Q3 | $332K | Buy |
965
+96
| +11% | +$33K | ﹤0.01% | 2247 |
|
|
2019
Q2 | $800K | Hold |
869
| – | – | ﹤0.01% | 2020 |
|
|
2019
Q1 | $1.39M | Buy |
869
+75
| +9% | +$120K | ﹤0.01% | 1851 |
|
|
2018
Q4 | $1.47M | Buy |
794
+4
| +0.5% | +$7.4K | ﹤0.01% | 1729 |
|
|
2018
Q3 | $1.87M | Sell |
790
-65
| -8% | -$154K | ﹤0.01% | 1727 |
|
|
2018
Q2 | $2.91M | Buy |
855
+48
| +6% | +$163K | ﹤0.01% | 1463 |
|
|
2018
Q1 | $2.29M | Buy |
807
+22
| +3% | +$62.5K | ﹤0.01% | 1548 |
|
|
2017
Q4 | $2.02M | Buy |
785
+37
| +5% | +$95.3K | ﹤0.01% | 1617 |
|
|
2017
Q3 | $2.12M | Buy |
748
+8
| +1% | +$22.7K | ﹤0.01% | 1553 |
|
|
2017
Q2 | $1.75M | Buy |
740
+64
| +9% | +$151K | ﹤0.01% | 1601 |
|
|
2017
Q1 | $1.73M | Buy |
676
+9
| +1% | +$23K | ﹤0.01% | 1557 |
|
|
2016
Q4 | $1.5M | Buy |
667
+305
| +84% | +$687K | ﹤0.01% | 1569 |
|
|
2016
Q3 | $907K | Buy |
362
+267
| +281% | +$669K | ﹤0.01% | 1435 |
|
|
2016
Q2 | $289K | Hold |
95
| – | – | ﹤0.01% | 1627 |
|
|
2016
Q1 | $304K | Buy |
95
+20
| +27% | +$64K | ﹤0.01% | 1578 |
|
|
2015
Q4 | $386K | Hold |
75
| – | – | ﹤0.01% | 1408 |
|
|
2015
Q3 | $239K | Buy |
75
+7
| +10% | +$22.3K | ﹤0.01% | 1623 |
|
|
2015
Q2 | $278K | Hold |
68
| – | – | ﹤0.01% | 1574 |
|
|
2015
Q1 | $276K | Buy |
68
+17
| +33% | +$69K | ﹤0.01% | 1540 |
|
|
2014
Q4 | $254K | Hold |
51
| – | – | ﹤0.01% | 1463 |
|
|
2014
Q3 | $212K | Buy |
+51
| New | +$212K | ﹤0.01% | 1481 |
|